Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Thorp Clay
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Clearside Biomedical, Inc.
G1 Therapeutics, Inc.
Phasebio Pharmaceuticals Inc
Vigil Neuroscience, Inc.
Clearside Biomedical, Inc.
Director
Avg. Two Year Performance
64%
Avg. Purchase Return
28%
Compound
83%
Avg. Sale Return
35%
Compound
Holdings:
3.59M
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Other
Other
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
